Teva North America recalls Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hun
Recalled September 14, 2016 · FDA recall D-1496-2016 · Teva North America
Hazard
CGMP Deviations · FDA Class II
Units
14,661 vials
Sold at
Nationwide and Puerto Rico
Description
CGMP Deviations
Product
Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01.
Manufacturer(s)
Teva North America
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →